Research & Studies
Ozempic for the Brain? Why the Big Alzheimer’s Trial Just Disappointed
A major phase 3 trial (EVOKE) found that semaglutide, the drug in Ozempic and Wegovy, did not slow Alzheimer's, even though it…
Research & Studies
Research & Studies
40 Million Teens Use Tobacco: WHO Calls for Flavor Bans and Ad Restrictions to Halt Nicotine Pouch and Vape Addiction
Quick Answer: The World Health Organization reports that at least 40 million children aged 13–15 currently use tobacco products, while e-cigarettes and…
Research & Studies
Bundibugyo Ebola: No Vaccine, No Cure – What the 2026 Outbreak Means for Global Health Security
Quick Answer: The 2026 Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo and Uganda has been declared a…
Research & Studies
Antimicrobial Resistance Could Kill 39 Million by 2050: WHO Assembly Adopts New 10-Year Plan to Avert Crisis
Quick Answer: At the 79th World Health Assembly in May 2026, countries approved an updated Global Action Plan on Antimicrobial Resistance (GAP-AMR…
Research & Studies
How the MYC Protein Helps Cancer Cells Survive Chemotherapy by Repairing DNA
Quick Answer: New research reveals that the cancer-driving MYC protein has a previously unknown role in directly repairing damaged DNA inside tumor…
Research & Studies
Brain Signals After Exercise May Be the Real Key to Building Stamina, Mouse Study Suggests
Quick Answer: New animal research suggests that exercise strengthens more than muscles—it trains the brain. Scientists found that certain brain cells remain…
Research & Studies
Nanoparticles Reverse Alzheimer’s Symptoms in Mice by Restoring the Brain’s Cleanup System
Quick Answer: Early-stage animal research shows that specially engineered nanoparticles can reverse Alzheimer’s-like symptoms in mice. The treatment works by clearing toxic…
Research & Studies
Adding a GLP-1/GIP Drug to Ixekizumab May Boost Psoriasis Clearance in People with Obesity, Early Trial Finds
Quick Answer: The open-label TOGETHER-PsO trial suggests that pairing a dual GLP-1/GIP receptor agonist with the biologic ixekizumab (Taltz) significantly improves outcomes…
Research & Studies
Balancing Opioid Prescriptions After Urologic Surgery: New Study Links Extremes to Higher Refill Rates
Quick Answer: A new study presented at a medical conference suggests that patients who receive either too much or too little opioid…
Research & Studies
Low-Intensity Ultrasound Breaks Up Kidney Stones with 70% Success Rate in SOUND Trial
Quick Answer: The Break Wave lithotripsy device, which uses low-pressure ultrasound waves delivered in an office setting, successfully fragmented kidney stones in…
Research & Studies
When Public Health Becomes Immigration Enforcement: The Hidden Health Toll of Sharing Medicaid Data
Quick Answer: A growing number of states are allowing public health agencies to share Medicaid records with immigration authorities, a shift that…
Research & Studies
Durvalumab Plus BCG Cuts Early Recurrence in High-Risk Bladder Cancer: What We Know So Far
Quick Answer: An early report suggests that adding the immunotherapy drug durvalumab (Imfinzi) to standard BCG treatment reduced early recurrences within the…